10.6084/m9.figshare.c.3644024_D3.v1
Melanie Mediavilla-Varela
Melanie
Mediavilla-Varela
Kingsley Boateng
Kingsley
Boateng
David Noyes
David
Noyes
Scott Antonia
Scott
Antonia
Additional file 3: of The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
Springer Nature
2016
Pirfenidone
Cisplatin
Non-small cell lung cancer
Cancer associated fibroblasts
2016-03-02 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_of_The_anti-fibrotic_agent_pirfenidone_synergizes_with_cisplatin_in_killing_tumor_cells_and_cancer-associated_fibroblasts/4467530
MTS assay showing the viability of A549 cells after 72-h treatment with a low dose of cisplatin (Cis; 10 μM) and low dose of pirfenidone (Pirf; 0.5 mg/mL) in the presence and absence of the MEK inhibitor U0126 (U; 10 μM). (PDF 3219 kb)